Garcia-Manero, G. Et Al. 2022. Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial. Blood , vol.139, no.4 , 624-629.

Garcia-Manero, G., Mufti, G. J., Fenaux, P., Buckstein, R., Santini, V., Díez-Campelo, M., ... Finelli, C.(2022). Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial. Blood , vol.139, no.4, 624-629.

Garcia-Manero, Guillermo Et Al. "Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial," Blood , vol.139, no.4, 624-629, 2022

Garcia-Manero, Guillermo Et Al. "Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial." Blood , vol.139, no.4, pp.624-629, 2022

Garcia-Manero, G. Et Al. (2022) . "Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial." Blood , vol.139, no.4, pp.624-629.

@article{article, author={Guillermo Garcia-Manero Et Al. }, title={Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial}, journal={Blood}, year=2022, pages={624-629} }